quantitative
Analysis v1
Strong Support

For people with heart disease who are already taking cholesterol-lowering pills, adding a drug called evolocumab can slash their bad cholesterol by about 60% in less than a year—bringing it down to very low levels.

74
Pro
0
Against

Evidence from Studies

Supporting (1)

74

Community contributions welcome

The study tested adding evolocumab to statins in heart disease patients and found it lowered bad cholesterol by 59%, just as claimed.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.